Recently, CHEK2 mutations were described in the context of endocrine cancer: one patient with a germline CHEK2 mutation with ACC was reported (6), and a pathogenic variant of the gene was documented in a patient with multiple endocrine gland tumors (7). The gene discussed is CHEK2; the disease is malignant endocrine neoplasm.